TCL Archive Bypass Budget Omits Needless Words: Faster Progress to Cost $421 Million More March 29, 1996
TCL Archive Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation June 29, 2012
TCL Archive Changes In Clinical Trials Mechanism Inevitable, But NCI Says It will Heed Critics Of Proposals April 18, 1986
TCL Archive Natcher: Multiple Year Funding Would Not be Approved If Presented As Request For Reprogramming March 22, 1985
